Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-18

Clinical Trial Update: Human Optokinetic Contrast Device (HOCD) to Measure Visual Function and Identify Patients With and Without Glaucoma [NA]

View source ↗

Summary

Clinical trial update on the HOCD device study for measuring visual function to identify patients with and without glaucoma; status terminated with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Benjamin Frankfort, MD, PhD | Conditions: Glaucoma | NA | Status: TERMINATED | Results posted: 2020-11-18